Samþykkt | Titill | Höfundur(ar) |
---|---|---|
30.4.2012 | Determination of half maximal inhibitory concentration (IC50) of several anticancer drugs for inhibiting CYP3A4 metabolism of midazolam | Íris Stella Heiðarsdóttir 1987- |
20.10.2009 | Effects of polymorphic NAT2 on thalidomide treatment in prostate cancer | Silja Þórðardóttir 1982- |
20.10.2009 | Influence of CYP11A1 (TTTTA)n polymorphism on disease progression, serum androgens, prognosis and risk in men with prostate cancer | Jóhann Gunnar Jónsson 1982- |